Equity Profile

BLTE

Belite Bio, Inc

Health CarePharmaceuticals$5.8B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Belite Bio, Inc. is a pharmaceutical company focused on developing innovative therapies for various health conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLTE Q2-2026 Earnings Preview

Context

Company Snapshot

Belite Bio, Inc. is a pharmaceutical company focused on developing innovative therapies for various health conditions. With a market cap of $6 billion, it operates in the health care sector, which is increasingly important as demand for new treatments continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-0.73%

Avg Stock Reaction

+0.56%

Last Quarter Recap

In Q1 2026, Belite Bio reported an EPS of -$0.34, which was better than the expected -$0.59, resulting in a positive surprise of 42.86%. The stock rose 2.62% the following day, reflecting investor optimism.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and the potential for positive surprises.

Bull Case

If Belite can continue to exceed EPS expectations, it may signal strong operational efficiency and market demand, potentially driving the stock higher.

Bear Case

Conversely, any failure to meet expectations could raise concerns about the company's growth prospects and lead to a decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2 2026?

The EPS figure will be crucial in determining whether the company can maintain its trend of positive surprises and investor confidence.

What revenue figures will Belite report?

Revenue will indicate market demand for Belite's products and is essential for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Belite's ability to leverage recent operational improvements, leading to better-than-expected EPS results.

Supporting Evidence

The company has a history of surprising on EPS, with a 42.86% surprise last quarter.

Options are pricing a significant move, indicating that traders expect volatility, which could favor a positive outcome.

Key Risk

If EPS comes in better than -$0.30, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reveal the company's ability to sustain growth and manage expenses effectively.

Bull Confirmed If

An EPS of -$0.30 or better would confirm the bull case, indicating improved profitability.

Bear Confirmed If

An EPS worse than -$0.50 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±20.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±20.3% while BLTE has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

38.6%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.7%, with a raw directional average of +3.1% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$4.1M

23,500 sh

4 insiders

Net

$4.1M

Net selling

Most Active Insiders· 54 open-market trades

Chief Scientific OfficerMATA NATHAN L.
$1.2M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Belite beats expectations, history suggests a potential stock increase of around 2.36%, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss could lead to a decline, with historical data indicating an average drop of around 1.06% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Insights into cost management strategies.
3Details on market conditions affecting sales.
4Guidance on future revenue projections.
5Management's outlook on competitive positioning.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug7

PAABMO

Plains All American Pipeline, L.P.

PreviewView

Aug7

ESNTBMO

Company Snapshot

Belite Bio, Inc. is a pharmaceutical company focused on developing innovative therapies for various health conditions....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BLTE Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-0.73%

Avg Stock Reaction

+0.56%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and the potential for positive surprises.

Bull Case

If Belite can continue to exceed EPS expectations, it may signal strong operational efficiency and market demand, potentially driving the stock higher.

Bear Case

Conversely, any failure to meet expectations could raise concerns about the company's growth prospects and lead to a decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2 2026?

The EPS figure will be crucial in determining whether the company can maintain its trend of positive surprises and investor confidence.

What revenue figures will Belite report?

Revenue will indicate market demand for Belite's products and is essential for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Belite's ability to leverage recent operational improvements, leading to better-than-expected EPS results.

Supporting Evidence

The company has a history of surprising on EPS, with a 42.86% surprise last quarter.

Options are pricing a significant move, indicating that traders expect volatility, which could favor a positive outcome.

Key Risk

If EPS comes in better than -$0.30, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reveal the company's ability to sustain growth and manage expenses effectively.

Bull Confirmed If

An EPS of -$0.30 or better would confirm the bull case, indicating improved profitability.

Bear Confirmed If

An EPS worse than -$0.50 would confirm the bear case, raising concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±20.33%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±20.3% while BLTE has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

38.6%

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$4.1M

23,500 sh

4 insiders

Net

$4.1M

Net selling

Most Active Insiders· 54 open-market trades

Chief Scientific OfficerMATA NATHAN L.
$1.2M
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Belite beats expectations, history suggests a potential stock increase of around 2.36%, reinforcing positive sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.

Miss

A miss could lead to a decline, with historical data indicating an average drop of around 1.06% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Insights into cost management strategies.
3Details on market conditions affecting sales.
4Guidance on future revenue projections.
5Management's outlook on competitive positioning.